12 Best Multibagger Stocks to Buy in 2025
In the world of investing, the term "multibagger" refers to stocks that have the potential to deliver returns several times greater than the original investment.
Summit Therapeutics Inc. (SMMT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lansdowne Partners Alex Snow | 0 | $0 | 0% | |
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | 0% | |
| 3. | Polar Capital Brian Ashford-Russell And Tim Woolley | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.71 | 20,000 | Officer, Director | 50,000 | 2024-03-27 | Filing | |
| $3.75 | 30,000 | Officer, Director | 30,000 | 2024-03-26 | Filing | |
| $3.72 | 34,321 | Officer, Director | 24,923,800 | 2024-03-27 | Filing | |
| $3.72 | 26,000 | Officer, Director | 520,814 | 2024-03-27 | Filing | |
| $3.75 | 100,000 | Officer | 354,958 | 2024-03-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.44 | 13,713 | Officer | 0 | 2020-11-30 | Filing | |
| $4.39 | 29,569 | Officer | 0 | 2020-11-27 | Filing | |
| $4.32 | 12,070 | Officer | 0 | 2020-11-25 | Filing | |
| $4.21 | 11,374 | Officer | 0 | 2020-11-24 | Filing | |
| $4.40 | 6,987 | Officer | 0 | 2020-11-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,067 | $179,646 | 0.01% | |
| 2. | 755 | $13,473 | 0% | |
| 3. | 418 | $7,460 | 0% | |
| 4. | 120 | $2,141 | 0% | |
| 5. | 45 | $803 | 0% |
News See All
10 Hot Growth Stocks to Invest in According to Analysts
The big rally in the broader stock market might have ceased, but there are a lot of things to focus on under the surface, says Morningstar.
Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2024 Earnings Call Transcript
Operator: Good morning and welcome to Summit Therapeutics Fourth Quarter and Year End 2024 Earnings and Update Call.
15 Stocks That Will Go to The Moon According to Analysts
While stocks initially fell based on worries regarding Trump tariffs on America’s major trading partners, major indexes recovered from their initial losses as the President delayed tariffs on Mexico...
12 Best Growth Stocks to Invest In According to Analysts
Companies experiencing above-average earnings growth, which is often fueled by innovations and market expansions, are known as growth stocks.
12 Best Healthcare Stocks to Buy According to Analysts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
Jim Cramer Recently Looked Into These 8 Stocks
Jim Cramer, the host of Mad Money, took to the airwaves last Friday to discuss the recent stir caused by DeepSeek in the tech world.
10 Unstoppable Stocks to Buy in 2025
As per the recent earnings update by FactSet dated 24th January 2025, the Q4 2024 earnings season for the S&P 500 has seen a strong start.
Why These 15 Stocks Are Skyrocketing in 2025
Stock gains always get people talking, and 2025 is no exception. Markets have moved higher for a while due to a shift toward tech innovation.
12 Hot Stocks to Buy According to Analysts
While the stock market in the United States remained closed on January 20 for Martin Luther King, Jr. Day, the day was happening with Donald Trump's inauguration on the same date.